quiet_lurker
TL2 Regular · Riga, LV
Two thousand posts read for every one written.
Joined 29 November 2024 · last posted 3d
64 posts, newest first. Showing up to 150.
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #30 · Sourcing › Vendor reports · 25 Jul 2026 · 20 likes Post #28 put the caveat in the right place and I want to underline it. Structured report format: compound, lot, independent testing service, method as reported, result,…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #23 · Analytics › HPLC & UHPLC · 9 Jul 2026 · 5 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
What a regulator's shortage notice actually authorises Replied, post #4 · Sourcing › Regulatory · 4 Jul 2026 · 3 likes Answering the question post #2 raises rather than the one it answers. Where a claim about legality is made here, the useful follow-up is which instrument it rests on.…
-
Pancreatitis history and the risk calculus Replied, post #25 · Safety › Contraindications · 4 Jul 2026 · 1 like Building on post #22 rather than restating it. Genuine question rather than a rhetorical one: has anyone here actually observed pancreatitis history, as opposed to read…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #53 · Sourcing › Independent verification · 30 Jun 2026 · 0 likes Post #52 describes the usual case. This is about the unusual one. Combining a chromatographic result with a documentation review gives a more complete picture than two…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #77 · Compounds › Semaglutide · 24 Jun 2026 · 0 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #30 · Compounds › Retatrutide · 5 Jun 2026 · 3 likes Coming back to post #26, because the follow-up matters more than the original answer. Two things can be true about TRIUMPH at once: the mechanism is plausible and the…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #27 · Analytics › Method validation · 20 May 2026 · 0 likes Post #24 answers the question as asked. The question underneath it is different. A method that reports the same number for every lot is worth a second look. Real…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #15 · Analytics › Home & field testing · 9 May 2026 · 15 likes Noted, and I have changed what I was going to do on the strength of it.
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #20 · Compounds › Tirzepatide · 4 May 2026 · 13 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #54 · Evidence › Journal club · 3 May 2026 · 10 likes On orforglipron phase 2, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #31 · Evidence › Preprints · 15 Apr 2026 · 9 likes Post #27 and I disagree about the size of the effect, not about the direction. Retractions and corrections do not propagate well from preprint servers. A citation that…
-
Follow-up: State-level differences that actually matter Replied, post #10 · Regional › North America · 4 Apr 2026 · 12 likes Adding a data point of agreement rather than a data point.
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #85 · Regional › UK & Ireland · 21 Mar 2026 · 3 likes The arithmetic in post #82 is right; the assumption feeding it is the part to check. Since pharmacy supply keeps coming up, it should probably be a maintained page…
-
Adolescents: a distinct evidence base — one year on Replied, post #77 · Clinical › Special populations · 21 Mar 2026 · 0 likes Almost every population discussed here was excluded from the pivotal trials, which means the evidence base is observational at best and absent at worst.
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #28 · Start Here › Welcome · 20 Mar 2026 · 0 likes Likes here mean "this helped", not "I agree". People like posts that argue against them, and that is deliberate. I am aware this is the third time this month I have…
-
Interim analyses and stopping rules Replied, post #15 · Evidence › Trials · 6 Mar 2026 · 0 likes Picking up post #14: that is the part I would want checked first. Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #116 · Access › International · 18 Feb 2026 · 0 likes Post #114 describes the usual case. This is about the unusual one. Language barriers in accessing has a well-known answer and a correct answer, and the interesting work…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #6 · Clinical › Comorbidities · 16 Feb 2026 · 5 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
A payment that went through twice: how it was resolved Replied, post #17 · Sourcing › Payments · 10 Feb 2026 · 1 like This follows post #14 rather than contradicting it. Fraud and scams: if a supplier demands payment upfront with no recourse if delivery fails, you are taking a risk.…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #21 · Research Methods › Statistics · 29 Jan 2026 · 1 like Two claims get bundled together under Measurement error in home scales and they need separating. The descriptive one — this is what was observed — is usually well…
-
A history of disordered eating: proceeding carefully Replied, post #56 · Wellbeing › Mental health · 10 Jan 2026 · 25 likes I disagree with the framing of history of disordered eating above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it…
-
Dead volume across syringe and needle combinations Replied, post #46 · Devices › Syringes & needles · 29 Dec 2025 · 0 likes A request rather than an answer: could whoever has the primary source for dead volume across syringe post it? I have seen the claim three times this month and each…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #23 · Clinical › Bloodwork · 15 Dec 2025 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Specification in the result column: why that is a meaningful error Replied, post #86 · Analytics › COA interpretation · 9 Dec 2025 · 16 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #60 · Wellbeing › Mental health · 8 Dec 2025 · 0 likes Everything in post #56 holds. The case it does not cover is the one I have. Where a member is finding this hard, the useful reply is usually a question rather than an…
-
Request: a diff view for wiki revisions — the long version Replied, post #74 · Meta › Feature requests · 24 Nov 2025 · 29 likes Building on post #71 rather than restating it. Asking for something deliberately narrow: a way to link to a range of posts rather than a single one. Half the good…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #64 · Compounds › Tirzepatide · 14 Nov 2025 · 10 likes Post #61 is the version of this I will quote in future. One addition. My experience of tirzepatide titration schedules contradicts the reply above. I am posting it as a…
-
[2026 update] What steady state means for the decision to escalate Replied, post #60 · Practice › Dosing & titration · 11 Nov 2025 · 3 likes I keep a log for steady state specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #80 · Sourcing › Vendor reports · 26 Oct 2025 · 17 likes Agreed on all of that, and I have nothing to add to it.
-
Documentation that materially improves an appeal's chances Replied, post #34 · Access › Insurance & coverage · 20 Oct 2025 · 7 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #108 · Data & Tools › Calculators · 7 Sep 2025 · 21 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
What this community means by "a source", in practical terms Replied, post #98 · Start Here › Welcome · 3 Sep 2025 · 2 likes This settles it for me, at least until somebody posts a reason it should not.
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #26 · Practice › Side effects · 30 Aug 2025 · 0 likes Adding the measurement that post #23 says would settle it. The version of nausea timeline that I was taught turned out to be a teaching simplification. Useful, and not…
-
Trial registration and comparing the protocol with the paper Replied, post #33 · Evidence › Trials · 27 Aug 2025 · 31 likes Building on post #30 rather than restating it. A trial that answers a slightly different question from the one you have is the normal situation rather than a failure of…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #112 · Wellbeing › Mental health · 16 Aug 2025 · 13 likes On post #109 — agreed on the reasoning, with one qualification. Eating-disorder history is raised here regularly and is the case where guidance most consistently…
-
A ten-fold dose error caught before injection — one year on Replied, post #36 · Devices › Syringes & needles · 2 Aug 2025 · 0 likes A detachable luer needle plus hub can retain enough volume to matter. Whether it matters to you depends on your dose, and the arithmetic is worth doing once.
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #63 · Data & Tools › Calculators · 26 Jul 2025 · 27 likes That is consistent with mine, for whatever one more account is worth.
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #6 · Sourcing › Regulatory · 25 Jul 2025 · 15 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post. Not a conclusion. A…
-
A field-by-field walk through a certificate of analysis Replied, post #95 · Analytics › COA interpretation · 17 Jul 2025 · 18 likes A note on how field-by-field walk through a certificate gets discussed rather than on field-by-field walk through a certificate itself: the confident posts get the…
-
Whether an aggregate is worth publishing at all: a disputed topic Replied, post #18 · Data & Tools › Datasets · 29 Jun 2025 · 0 likes Post #16 answers the question as asked. The question underneath it is different. Licence and reuse terms are worth stating even informally. People will reuse it, and…
-
Follow-up: How much fluid is actually needed, and how you would know Replied, post #21 · Nutrition & Training › Hydration & electrolytes · 11 Jun 2025 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #65 · Compounds › Retatrutide · 10 Jun 2025 · 22 likes Post #64 and I disagree about the size of the effect, not about the direction. Taking Retatrutide mass and identity seriously for a moment rather than deflecting: the…
-
Sodium, potassium and magnesium when intake drops Replied, post #6 · Nutrition & Training › Hydration & electrolytes · 5 Jun 2025 · 3 likes Nobody has said the unglamorous part of sodium yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
Ipamorelin selectivity claims and where they came from Replied, post #40 · Compounds › Secretagogues & GH axis · 23 May 2025 · 11 likes Post #36 and I disagree about the size of the effect, not about the direction. Research-use-only secretagogues are not approved for human use. That statement is doing…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #64 · Practice › Interactions · 28 Apr 2025 · 10 likes What I would check first on delayed gastric emptying and oral is whether the thing being measured moved or whether the way of measuring it moved. Those look identical…
-
Coming back to: A critique that turned out to be unfair, retracted by its author Replied, post #2 · Evidence › Study critique · 23 Apr 2025 · 8 likes That is a cleaner way of putting what I was circling around.
-
Reading a supplier's product description as a marketing document Replied, post #13 · Compounds › Other compounds · 15 Apr 2025 · 0 likes Solubility varies far more across this subcategory than within the incretins. A compound that needs a specific diluent or a specific pH is not being difficult; it has a…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #108 · Analytics › COA interpretation · 21 Mar 2025 · 30 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #44 · Pharmacology › Receptor biology · 5 Mar 2025 · 1 like Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
-
Micronutrient status when intake falls substantially — a second dataset Replied, post #10 · Clinical › Bloodwork · 4 Mar 2025 · 0 likes Following this. I have the same question and no better information than the first post.
-
Consistent declarations and why they matter more than clever ones Replied, post #57 · Sourcing › Logistics · 20 Feb 2025 · 24 likes Reading this consistent declarations thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #49 · Practice › Interactions · 15 Jan 2025 · 0 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
-
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #19 · Compounds › Tirzepatide · 11 Jan 2025 · 0 likes Post #17 answers the question as asked. The question underneath it is different. Titration schedules for tirzepatide have more dose steps than semaglutide partly…
-
Follow-up: Individual participant data versus aggregate data Replied, post #46 · Evidence › Meta-analyses · 9 Jan 2025 · 0 likes Summarising the Individual participant data versus aggregate thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #80 · Clinical › Comorbidities · 22 Oct 2024 · 19 likes Post #79 is the version of this I will quote in future. One addition. Nothing here is medical advice and clinicians posting in this subcategory say so on their own…
-
Reading a supplementary appendix and finding the interesting part Replied, post #9 · Evidence › Trials · 20 Oct 2024 · 14 likes Discontinuation handling is the methodological detail that most changes a result and gets the least attention. Read how missing data was imputed before reading the…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #117 · Clinical › Bloodwork · 17 Oct 2024 · 12 likes Coming back to post #115, because the follow-up matters more than the original answer. Trying to state the bring a laboratory position in a way that someone who…
-
Request: a diff view for wiki revisions Replied, post #11 · Meta › Feature requests · 15 Sep 2024 · 23 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Chronic kidney disease and the FLOW result Replied, post #23 · Clinical › Comorbidities · 17 Aug 2024 · 0 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #73 · Analytics › COA interpretation · 14 Aug 2024 · 18 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #3 · Evidence › Journal club · 23 Jul 2024 · 12 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #143 · Practice › Dosing & titration · 10 Jul 2024 · 0 likes Post #141 describes the usual case. This is about the unusual one. Doubling after a miss adds a peak for no gain and is not what any labelling in this class recommends.…
-
Cold packs, phase-change material, and what survives ten days Replied, post #32 · Sourcing › Logistics · 21 Jun 2024 · 30 likes Good question, well framed, and I would like to see it answered properly.